Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05637801Not ApplicableActive Not Recruiting

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Role: lead

NCT06245031Not ApplicableEnrolling By Invitation

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Role: lead

NCT03661034Not ApplicableUnknown

Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

Role: lead

NCT03556280Not ApplicableActive Not Recruiting

Multi-Center Study of Sensory Stimulation to Improve Brain Function

Role: lead

All 4 trials loaded